<DOC>
	<DOC>NCT00015210</DOC>
	<brief_summary>The purpose of this study is the use of Nefazodone in the treatment of cocaine dependence and depression comorbidity.</brief_summary>
	<brief_title>Nefazodone in the Treatment of Cocaine Dependence and Depression - 4</brief_title>
	<detailed_description>The objective of this study is to determine the safety and efficacy of nefazodone (Serzone ) in depressed cocaine dependent subjects. This is a hypothesis-testing study which will explore whether cocaine usage will be reduced in the nefazodone treatment group compared to a placebo control group.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Nefazodone</mesh_term>
	<criteria>DSMIV diagnosis of cocaine dependence, Depression score of 12 or above and history of depression. Males and nonpregnant, nonnursing females 2155 years of age. Axis I diagnosis other than substance use disorder, major depression, anxiety of dysthymic disorder. Physiological dependence on alcohol. Significant medical or neurological history. Abnormal UA, CBC or Chem 23 (LFT's may be up to 3 times normal). Enrollment in an opiatesubstitution treatment program within 45 days of enrollment in the present study.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Cocaine Use Disorders Dependence Depression</keyword>
</DOC>